GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bionoid Pharma Inc (OTCPK:BINP) » Definitions » FCF Margin %

Bionoid Pharma (Bionoid Pharma) FCF Margin % : 0.00% (As of Mar. 2011)


View and export this data going back to 2007. Start your Free Trial

What is Bionoid Pharma FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bionoid Pharma's Free Cash Flow for the three months ended in Mar. 2011 was $-0.67 Mil. Bionoid Pharma's Revenue for the three months ended in Mar. 2011 was $0.00 Mil. Therefore, Bionoid Pharma's FCF Margin % for the quarter that ended in Mar. 2011 was 0.00%.

As of today, Bionoid Pharma's current FCF Yield % is 0.00%.

The historical rank and industry rank for Bionoid Pharma's FCF Margin % or its related term are showing as below:


BINP's FCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.235
* Ranked among companies with meaningful FCF Margin % only.


Bionoid Pharma FCF Margin % Historical Data

The historical data trend for Bionoid Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionoid Pharma FCF Margin % Chart

Bionoid Pharma Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10
FCF Margin %
- - - - -

Bionoid Pharma Quarterly Data
Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Bionoid Pharma's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Bionoid Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bionoid Pharma's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bionoid Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Bionoid Pharma's FCF Margin % falls into.



Bionoid Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Bionoid Pharma's FCF Margin for the fiscal year that ended in Dec. 2010 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2010 )/Revenue (A: Dec. 2010 )
=-1.745/0
= %

Bionoid Pharma's FCF Margin for the quarter that ended in Mar. 2011 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2011 )/Revenue (Q: Mar. 2011 )
=-0.665/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bionoid Pharma FCF Margin % Related Terms

Thank you for viewing the detailed overview of Bionoid Pharma's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bionoid Pharma (Bionoid Pharma) Business Description

Traded in Other Exchanges
N/A
Address
433 N Camden Dr, Beverly Hills, CA, USA, 90210
Bionoid Pharma Inc is a cannabis company that cultivates, extracts, tests, and distributes organic hemp, cannabinoid, and related products. Its products aid in decreasing pain, improving recovery time, enhancing performance, and enhance physical well-being.